Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Loap

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|July 16, 2021
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Acta Oncologica (Stockholm, Sweden)|October 12, 2023
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centreLouis-Marie Sauvage, Pierre Loap, Jeremi Vu-Bezin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2025
Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Marc-Henri Stern, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Mediastinum (Hong Kong, China)|February 7, 2024
Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experiencePierre Loap, Radouane El Ayachy, Arnaud Beddok, et al.
Practical Radiation Oncology|June 9, 2023
Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast CancerMaximilien Rogé, Youlia Kirova, Pierre Loap, et al.
Critical Reviews in Oncology/Hematology|December 27, 2021
Hadrontherapy techniques for breast cancerPierre Loap, Ludovic De Marzi, Carlos Eduardo Almeida, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2025
Cardiac Outcomes Following Adjuvant Radiation Therapy in Triple-Negative Breast Cancer Patients With Prior Autoimmune MyocarditisPierre Loap, Assile El Fakih, Clara Helal, et al.
Cancers|August 7, 2021
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and PerspectivesPierre Loap, Ludovic De Marzi, Alfredo Mirandola, et al.
Cancers|August 7, 2021
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to EvidencePierre Loap, Alfredo Mirandola, Ludovic De Marzi, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|July 16, 2021
Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Acta Oncologica (Stockholm, Sweden)|October 12, 2023
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centreLouis-Marie Sauvage, Pierre Loap, Jeremi Vu-Bezin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2025
Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Marc-Henri Stern, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Mediastinum (Hong Kong, China)|February 7, 2024
Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experiencePierre Loap, Radouane El Ayachy, Arnaud Beddok, et al.
Practical Radiation Oncology|June 9, 2023
Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast CancerMaximilien Rogé, Youlia Kirova, Pierre Loap, et al.
Critical Reviews in Oncology/Hematology|December 27, 2021
Hadrontherapy techniques for breast cancerPierre Loap, Ludovic De Marzi, Carlos Eduardo Almeida, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2025
Cardiac Outcomes Following Adjuvant Radiation Therapy in Triple-Negative Breast Cancer Patients With Prior Autoimmune MyocarditisPierre Loap, Assile El Fakih, Clara Helal, et al.
Cancers|August 7, 2021
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and PerspectivesPierre Loap, Ludovic De Marzi, Alfredo Mirandola, et al.
Cancers|August 7, 2021
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to EvidencePierre Loap, Alfredo Mirandola, Ludovic De Marzi, et al.
Pageof 12